|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 20563 |
FusionGeneSummary for MAGED1_LUC7L |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MAGED1_LUC7L | Fusion gene ID: 20563 | Hgene | Tgene | Gene symbol | MAGED1 | LUC7L | Gene ID | 9500 | 55692 |
| Gene name | MAGE family member D1 | LUC7 like | |
| Synonyms | DLXIN-1|NRAGE | LUC7B1|Luc7|SR+89|hLuc7B1 | |
| Cytomap | Xp11.22 | 16p13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | melanoma-associated antigen D1MAGE tumor antigen CCFMAGE-D1 antigenmelanoma antigen family D, 1melanoma antigen family D1neurotrophin receptor-interacting MAGE homolog | putative RNA-binding protein Luc7-like 1putative SR protein LUC7B1sarcoplasmic reticulum protein LUC7B1 | |
| Modification date | 20180522 | 20180523 | |
| UniProtAcc | Q9Y5V3 | Q9NQ29 | |
| Ensembl transtripts involved in fusion gene | ENST00000375772, ENST00000375722, ENST00000326587, ENST00000375695, ENST00000494718, | ENST00000293872, ENST00000337351, ENST00000397783, ENST00000397780, ENST00000494366, | |
| Fusion gene scores | * DoF score | 4 X 4 X 2=32 | 11 X 10 X 6=660 |
| # samples | 4 | 12 | |
| ** MAII score | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(12/660*10)=-2.4594316186373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: MAGED1 [Title/Abstract] AND LUC7L [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | MAGED1 | GO:0050680 | negative regulation of epithelial cell proliferation | 15930293 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BE904219 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000375772 | ENST00000293872 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375772 | ENST00000337351 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375772 | ENST00000397783 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375772 | ENST00000397780 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375772 | ENST00000494366 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375722 | ENST00000293872 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375722 | ENST00000337351 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375722 | ENST00000397783 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375722 | ENST00000397780 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375722 | ENST00000494366 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000326587 | ENST00000293872 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000326587 | ENST00000337351 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000326587 | ENST00000397783 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000326587 | ENST00000397780 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000326587 | ENST00000494366 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375695 | ENST00000293872 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375695 | ENST00000337351 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375695 | ENST00000397783 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375695 | ENST00000397780 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 5CDS-intron | ENST00000375695 | ENST00000494366 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 3UTR-intron | ENST00000494718 | ENST00000293872 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 3UTR-intron | ENST00000494718 | ENST00000337351 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 3UTR-intron | ENST00000494718 | ENST00000397783 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 3UTR-intron | ENST00000494718 | ENST00000397780 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
| 3UTR-intron | ENST00000494718 | ENST00000494366 | MAGED1 | chrX | 51640721 | + | LUC7L | chr16 | 313297 | + |
Top |
FusionProtFeatures for MAGED1_LUC7L |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MAGED1 | LUC7L |
| Involved in the apoptotic response after nerve growthfactor (NGF) binding in neuronal cells. Inhibits cell cycleprogression, and facilitates NGFR-mediated apoptosis. May act as aregulator of the function of DLX family members. May enhanceubiquitin ligase activity of RING-type zinc finger-containing E3ubiquitin-protein ligases. Proposed to act through recruitmentand/or stabilization of the Ubl-conjugating enzyme (E2) at theE3:substrate complex. Plays a role in the circadian rhythmregulation. May act as RORA co-regulator, modulating theexpression of core clock genes such as ARNTL/BMAL1 and NFIL3,induced, or NR1D1, repressed. {ECO:0000269|PubMed:20864041}. | May bind to RNA via its Arg/Ser-rich domain.{ECO:0000269|PubMed:11170747}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for MAGED1_LUC7L |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for MAGED1_LUC7L |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for MAGED1_LUC7L |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for MAGED1_LUC7L |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|